Thanks, and maybe picking November is being too selective, but it was the point of my investment thesis. A recovery favors beaten up stocks.
Speaking of which, Whitecap (WCP) is currently $4.01/share, but a year ago it was $4.04/share. Has the Covid recovery already happened for Whitecap?
https://ca.finance.yahoo.com/quote/WCP.TO?p=WCP.TOWhat do you think of Vanguard Energy sector ETF (VDE)?
Vanguard's VDE is down 1/3rd, which in a recovery potentially translates to +50%. When I look at WCP, I see it's down 1/4th, so it has about +33% to rise before it breaks even / recovers. Not only does VDE have more upside potential, but it invests in 115 companies instead of just 1.
---
Yesterday, considering the uncertainty of the OPEC+ meeting, rising cases, and having 10% in cash, I increased my investment in Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares (aka, "GUSH"). It's underlying index, which I believe is XOP, gained +34% in November. GUSH in that same month gained about twice as much, +72%.
Note that derivative ETFs like GUSH cannot "recover", and have weird characteristics. An example is probably better than a description, so take the S&P 500 and a 3X S&P 500 ETF ("UPRO"). How did they perform in the past 12 months?
S&P 500, "VOO", gained +20%. UPRO, with triple the price moves, gained +15%.
https://etfdb.com/etf/VOO/#performancehttps://etfdb.com/etf/UPRO/#performanceIf there's too much volatility, GUSH could perform worse than XOP. But with vaccine news ahead, I'm investing on there being more upside than downside.